IP Library Granted Patent US 10,327,443
Granted Patent B2
US 10,327,443 · App. 15/207,303 · Granted Jun 25, 2019

Systems for monitoring and applying electrical currents in an organ perfusion system

Inventors: Waleed H. Hassanein (North Andover, MA); Ahmed Elbetanony (North Andover, MA); Richard Bringham (North Andover, MA); Robert Havener (Lynnfield, MA); Vincent Lambert, II (Salisbury, MA); Burt Ochs (Andover, MA)
Assignee: TRANSMEDICS, INC.
A01N1/0247A01N1/0294A61N1/046A61N1/0488A61N1/0492
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,327,443
App. No.
15/207,303
Granted
Jun 25, 2019
Kind
B2
Abstract

Electrode systems have been developed for use in perfusion systems to measure the electrical activity of an explanted heart and to provide defibrillation energy as necessary. The perfusion systems maintain the heart in a heating state at, or near, normal physiological conditions; circulating oxygenated, nutrient enriched perfusion fluid to the heart at or near physiological temperature, pressure and flow rate. These systems include a pair of electrodes that are placed epicardially on the right atrium and left ventricle of the explanted heart, as well as an electrode placed in the aortic blood path.

Claims (10)

1. A system for monitoring the electrical activity of an explanted organ, the system comprising:

an organ chamber assembly configured to contain an explanted heart;

a first electrode placed in the aortic bloodstream conduit outside the organ chamber assembly;

a second electrode placed epicardially on the heart within the organ chamber assembly;

a third electrode placed epicardially on the heart within the organ chamber assembly;

a controller configured to provide an interface between at least one of the first, second, and third electrode and a defibrillation source wherein the controller receives signals from at least one of the first, second, and third electrode;

a perfusion fluid; and

a heater assembly that heats the perfusion fluid to a temperature between 26° and 37° C.

2. The system of claim 1 further comprising a pump configured to provide perfusion fluid to the system wherein the signals received by the controller are used to determine the rate at which the pump provides perfusion fluid to the system.

3. The system of claim 2 further comprising an interface between the heater assembly and the controller wherein the controller receives signals from at least one of the first, second, and third electrode and from the heater assembly wherein the signals received by the controller are used to determine the temperature at which the heater assembly heats the perfusion fluid.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 25, 2022
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: TRANSMEDICS, INC.
Reel/Frame 060610/0023 →
SECURITY INTEREST Recorded Jun 22, 2018
From: TRANSMEDICS, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 046179/0223 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2016
From: HASSANEIN, WALEED; ELBETANONY, AHMED; BRINGHAM, RICHARD; HAVENER, ROBERT; LAMBERT, VINCENT, II; OCHS, BURT
To: TRANSMEDICS, INC.
Reel/Frame 039355/0476 →
Continuity (3)
Continuation 11822495 · Jul 6, 2007
Provisional Application 60919306 · Mar 20, 2007
Related Publication 20160374332A1 · Dec 29, 2016
Cited By (3)
US 12,186,575 US 12,440,843 US 12,521,564